Search Videos and More

Showing 1 - 12 of 31 results

Previous| 1 | 2 | 3 |Next


SELECTing Treatments for Cardiovascular Disease — Obesity in the Spotlight News

SELECTing Treatments for Cardiovascular Disease — Obesity in the Spotlight

Amit Khera, M.D., Director of UT Southwestern’s Preventive Cardiology Program, co-authored a widely circulated editorial in the New England Journal of Medicine that captured the impact of the SELECT trial, which made headlines in November at the annual AHA Scientific Sessions conference.
UTSW studies the tip-in and rendezvous techniques in retrograde chronic total occlusion percutaneous coronary interventions News

UTSW studies the tip-in and rendezvous techniques in retrograde chronic total occlusion percutaneous coronary interventions

Interventional cardiologist Salman Allana, M.D., Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, is a first author on a scientific research paper published in EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI).
Standing blood pressure test more accurate in detecting hypertension News

Standing blood pressure test more accurate in detecting hypertension

Measurements more reliable than those taken while patients are sitting, UT Southwestern researchers find
Cardio-Oncology Program Recognized as Global Center of Excellence News

Cardio-Oncology Program Recognized as Global Center of Excellence

The program was one of few in the world to be recognized with the highest distinction in 2022 by the International Cardio-Oncology Society.
UTSW Study Finds Blood Pressure Rose During the Pandemic News

UTSW Study Finds Blood Pressure Rose During the Pandemic

Moderate rises seen among people monitoring blood pressure, greater rises possible in general population
In-Depth and Fresh Look at Heart Failure Clinical Trials News

In-Depth and Fresh Look at Heart Failure Clinical Trials

At #AHA22, I co-chaired a Featured Science session with Alanna Morris, M.D., M.Sc., from Emory University. Principal investigators of several, recently published pivotal clinical trials in heart failure presented their findings of pre-specified, secondary analyses.
Brady- and Tachyarrhythmias Following Heart Transplantation: Significance and Management Strategies News

Brady- and Tachyarrhythmias Following Heart Transplantation: Significance and Management Strategies

It was my pleasure to participate in the cardiovascular seminar “Arrhythmias and Heart Failure: Breaking the Vicious Cycle” at #AHA22. Within context of the seminar’s focus on the management of arrhythmias in patients with heart failure, my lecture addressed the clinical significance and management of arrhythmias in patients who have received a heart transplant.
Diagnostic Delays in Patients with MI from Spontaneous Coronary Artery Dissection News

Diagnostic Delays in Patients with MI from Spontaneous Coronary Artery Dissection

Spontaneous coronary artery dissection (SCAD) is an important but under-recognized cause of acute coronary syndromes, particularly among young women without traditional cardiovascular risk factors.
UT Southwestern Appoints New Chief of Cardiology News

UT Southwestern Appoints New Chief of Cardiology

Dr. de Lemos received his medical degree from Harvard Medical School and completed internal medicine residency training at UT Southwestern, where he served as Chief Resident.
Two Impactful Heart Failure Trials News

Two Impactful Heart Failure Trials

I congratulate the organizers of #AHA22 for another wonderful conference.
UTSW cardiologist receives NIH Outstanding Investigator Award News

UTSW cardiologist receives NIH Outstanding Investigator Award

Hesham Sadek, M.D., Ph.D., says he will use the seven years of award funds to identify molecular mechanisms through which cardiac work and oxygenation regulate the heart's ability to regenerate.
Chimeric Antigen Receptor (CAR) T-Cell Therapy and Cardiovascular Risks News

Chimeric Antigen Receptor (CAR) T-Cell Therapy and Cardiovascular Risks

Chimeric antigen receptor (CAR) T-cell therapy is a personalized, genetically engineered cellular therapy that has revolutionized the treatment of refractory multiple myeloma and large B-cell lymphoma.

Showing 1 - 12 of 31 results

Previous| 1 | 2 | 3 |Next